Stephanie Demeyer1,2, Kris De Boeck3, Peter Witters3, Katrien Cosaert4. 1. Universitaire Ziekenhuizen Leuven, Leuven, Vlaams-Brabant, Belgium. stephanie.demeyer@uzleuven.be. 2. Department of Pediatrics, University Hospital Gasthuisberg, Herestraat 49, Leuven, 3000, Belgium. stephanie.demeyer@uzleuven.be. 3. Department of Pediatrics, University Hospital Gasthuisberg, Herestraat 49, Leuven, 3000, Belgium. 4. Department of Pharmocology, University Hospital Gasthuisberg, Herestraat 49, Leuven, 3000, Belgium.
Abstract
UNLABELLED: Cystic fibrosis is a life shortening hereditary disease, primarily leading to progressive pulmonary infection and exocrine pancreatic dysfunction. Several gastrointestinal complications other than malabsorption can arise during the disease course and with the progressively increasing life span of patients with CF; new and more rare complications are being recognized. We review the literature on gastrointestinal manifestations in CF, excluding the liver and pancreas. CONCLUSION: We describe the clinical presentation and treatment of more common conditions like gastroesophageal reflux, small intestinal bacterial overgrowth, intussusception, meconium ileus, distal intestinal obstruction syndrome, and constipation, and we also discuss what is known on celiac disease, appendicitis, fibrosing colonopathy, inflammation and inflammatory bowel disease and gastrointestinal cancer. WHAT IS KNOWN: • Gastrointestinal complications arise early in the course of the disease and have a severe impact on the quality of life of the patients. What is New: • This review is a concise summary of the current literature on gastrointestinal complications of cystic fibrosis. • We focused on clinical presentation and diagnostic investigations and provide a comprehensive resume of the current treatment options.
UNLABELLED: Cystic fibrosis is a life shortening hereditary disease, primarily leading to progressive pulmonary infection and exocrine pancreatic dysfunction. Several gastrointestinal complications other than malabsorption can arise during the disease course and with the progressively increasing life span of patients with CF; new and more rare complications are being recognized. We review the literature on gastrointestinal manifestations in CF, excluding the liver and pancreas. CONCLUSION: We describe the clinical presentation and treatment of more common conditions like gastroesophageal reflux, small intestinal bacterial overgrowth, intussusception, meconium ileus, distal intestinal obstruction syndrome, and constipation, and we also discuss what is known on celiac disease, appendicitis, fibrosing colonopathy, inflammation and inflammatory bowel disease and gastrointestinal cancer. WHAT IS KNOWN: • Gastrointestinal complications arise early in the course of the disease and have a severe impact on the quality of life of the patients. What is New: • This review is a concise summary of the current literature on gastrointestinal complications of cystic fibrosis. • We focused on clinical presentation and diagnostic investigations and provide a comprehensive resume of the current treatment options.
Entities:
Keywords:
Cystic fibrosis; Diagnosis and treatment; Gastrointestinal complications; Symptoms
Authors: Adria A Condino; Edward J Hoffenberg; Frank Accurso; Chureeporn Penvari; Meg Anthony; Jane Gralla; Judith A O'Connor Journal: J Pediatr Gastroenterol Nutr Date: 2005-07 Impact factor: 2.839
Authors: Patrick Maisonneuve; Stacey C FitzSimmons; Joseph P Neglia; Preston W Campbell; Albert B Lowenfels Journal: J Natl Cancer Inst Date: 2003-03-05 Impact factor: 13.506
Authors: H P J van der Doef; F T M Kokke; F J A Beek; J W Woestenenk; S P Froeling; R H J Houwen Journal: J Cyst Fibros Date: 2009-12-08 Impact factor: 5.482
Authors: Hubert P J van der Doef; Hubertus G M Arets; Steven P Froeling; Paul Westers; Roderick H J Houwen Journal: J Pediatr Date: 2009-08-14 Impact factor: 4.406
Authors: Jinghui Gao; Sophia Petraki; Xingshen Sun; Leonard A Brooks; Thomas J Lynch; Chih-Lin Hsieh; Reem Elteriefi; Zareeb Lorenzana; Vasu Punj; John F Engelhardt; Kalpaj R Parekh; Amy L Ryan Journal: Am J Physiol Lung Cell Mol Physiol Date: 2020-02-19 Impact factor: 5.464
Authors: Anke Jaudszus; Elisa Zeman; Tatjana Jans; Elena Pfeifer; Harold Tabori; Christin Arnold; Ruth K Michl; Michael Lorenz; Natalie Beiersdorf; Jochen G Mainz Journal: Patient Date: 2019-08 Impact factor: 3.883
Authors: Kenichi V Okuda; Jutta Hammermann; Björn S Lange; Jana C Fischer; Falk Thielemann; Ralf Knöfler; Meinolf Suttorp Journal: Mol Clin Oncol Date: 2017-05-29
Authors: Julia Hankel; Anne Mößeler; Clara Berenike Hartung; Silke Rath; Lisa Schulten; Christian Visscher; Josef Kamphues; Marius Vital Journal: Int J Mol Sci Date: 2022-10-02 Impact factor: 6.208